Downregulation of cardiac AT1-receptor expression and angiotensin II concentrations after long-term blockade of the renin-angiotensin system in cardiomyopathic hamsters

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 3, 1999, Pages 402-406

  Bastien, Natacha R ^a   Servant, Marc J ^b   Gutkowska, Jolanta ^b   Meloche, Sylvain ^a,b   Lambert, Chantal ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

AT1 receptors; Cardiac angiotensin II; Cardiac hypertrophy; Cardiomyopathic hamsters

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; LOSARTAN; PLACEBO; QUINAPRIL; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR;

ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HAMSTER; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; BINDING COMPETITION; BIOSYNTHESIS; CARDIOMEGALY; DOWN REGULATION; DRUG ANTAGONISM; HEART VENTRICLE; METABOLISM; PHYSIOLOGY; SYRIAN HAMSTER;

ANGIOTENSIN II; ANIMALS; BINDING, COMPETITIVE; CARDIOMEGALY; CRICETINAE; DOWN-REGULATION; HEART VENTRICLES; LOSARTAN; MALE; MESOCRICETUS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032586734     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199909000-00013     Document Type: Article

References (22)

1. Halleen ST, Weishaar RE, Overhiser RW, et al. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster: hemodynamic, morphological and biochemical correlates. Circ Res 1991;68:1302-12.
2. 1 receptors in congenital cardiomyopathic hamsters. Circ Res 1995;77:1001-7.
3. 1 receptor blockade and ACE inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival. Cardiovasc Res 1999;43:77-85.
4. De Léan A, Hancock AA, Lefkowitz RJ. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 1982;21:5-16.
5. De Silva PE, Husain A, Smeby RR, Khairallah PA. Measurement of immunoreactive angiotensin peptides in rat tissues: some pitfalls in angiotensin II analysis. Anal Biochem 1988;174:80-7.
6. Griendling KK, Delafontaine P, Rittenhouse SE, Gimbrone MA Jr, Alexander RW. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J Biol Chem 1987;262: 14555-62.
7. Böhm SK, Grady EF, Bunnett NW. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J 1997;322:1-18.
8. 1a angiotensin II receptor induces its constitutive activation. J Biol Chem 1997;272:1822-6.
9. Barker EL, Westphal RS, Schmidt D, Sanders-Bush E. Constitutively active 5-hydroxytryptamine 2c receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem 1994;269: 11687-90.
10. 1 antagonists. J Cardiovasc Pharmacol 1995;26: 66-72.
11. Raya TE, Fonkel SJ, Lee RW, et al. Hemodynamic effects of direct angiotensin blockade compared to converting enzyme inhibition in rat model of heart failure. Am J Hypertens 1991;4:3345-405.
12. Liu YH, Yang XP, Sharov VG, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997;99:1926-35.
13. Milavetz JJ, Raya TE, Johnson CS, Morkin E, Goldman S. Survival after myocardial infarction in rats: captopril versus losartan. J Am Coll Cardiol 1996;27:714-9.
14. 1 receptor inhibition: effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation 1997;95:1592-600.
15. 1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Cardiovasc Res 1998;39:401-12.
16. 1 receptor antagonist, TCV 116, does not prevent cardiac hypertrophy in salt-loaded Dahl salt-sensitive rats. Clin Exp Pharmacol Physiol 1996;23:282-6.
17. O'Sullivan JB, Black MJ, Bertram JF, Bobik A. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II? J Hypertens 1994;12:1163-70.
18. Spinale FG, Holzgrefe HH, Mukherjee R, et al. Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy: effects on left ventricular and myocyte structure and function. Circulation 1995;92:562-78.
19. 1 receptor inhibition in pacing induced heart failure: effects on left ventricular myocardial collagen content and composition. J Mol Cell Cardiol 1998;30:2355-64.
20. Lanza GM, Scott MJ, Davison G, et al. Angiotensin II receptor blockade in Syrian hamster (T0-2) cardiomyopathy does not affect microscopic cardiac material properties: implications for mechanisms of tissue remodeling. Cardiovasc Drugs Ther 1997;11: 521-9.
21. Davison G, Hall CS, Miller JG, Scott M, Wickline SA. Cellular mechanisms of captopril-induced matrix remodeling in Syrian hamster cardiomyopathy. Circulation 1994;90:1334-42.
22. Harada K, Komuro I, Yunzeng Z, et al. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice. Circ Res 1998;82:779-85.